한글목차

세계의 첨단 상처 치료 시장 규모는 2024년에 111억 8,000만 달러로 평가되었고, 2030년에는 148억 달러에 이를 전망이며, 예측 기간 중 CAGR 4.75%로 성장할 것으로 예측됩니다.

이 시장은 만성 및 급성 상처 증가, 혁신적인 상처 치료 제품에 대한 수요 증가, 의료 기술의 지속적인 진보 등으로 꾸준한 성장을 이루고 있습니다. 첨단 상처 치료는 기존의 방법과 비교하여 보다 빠르고, 보다 효율적인 치유 결과를 가져와 병원과 재택 케어 모두에서 널리 채택되고 있습니다. 이 분야에는 생체활성드레싱재, 음압상처치료, 기타 고성능 솔루션 등 다양한 제품이 포함됩니다. 세계의 수요는 왕성하지만, 특히 고령화 사회 및 만성 질환을 가진 사람들 사이에서는, 제품 비용의 높은 가격이 가격에 민감한 지역에서의 폭넓은 채용에 방해가 되고 있습니다.

시장 성장 촉진요인

담도 질환 증가

주요 시장 과제

첨단 상처 치료 제품의 높은 비용

주요 시장 동향

재생 의학 및 생물 제제에 대한 관심 증가

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 첨단 상처 치료 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 제품별(보습, 항균, 활성)
  • 용도별(만성 상처, 급성 상처)
  • 최종 사용자별(병원, 전문 클리닉, 재택 헬스케어, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 첨단 상처 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 첨단 상처 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 첨단 상처 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 첨단 상처 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 첨단 상처 치료 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 최근 동향
• 제품 출시
• 합병 및 인수

제13장 세계의 첨단 상처 치료 시장 : SWOT 분석

제14장 경쟁 구도

• Convatec Group PLC
• Smith Nephew
• Molnlycke AB
• B. Braun SE
• 3M Company
• Urgo Group
• Coloplast Corp
• Integra LifeSciences Corporation
• Medline Industries, LP.
• Boston Scientific Corporation.

제15장 전략적 제안

제16장 기업 소개 및 면책사항

영문목차

The Global Advanced Wound Care Market was valued at USD 11.18 billion in 2024 and is projected to reach USD 14.80 billion by 2030, growing at a CAGR of 4.75% during the forecast period. The market has seen steady growth, largely driven by the increasing prevalence of chronic and acute wounds, the rising demand for innovative wound care products, and ongoing advancements in medical technology. Advanced wound care offers faster, more efficient healing outcomes compared to traditional methods and is widely adopted in both hospital and home care settings. The sector includes diverse offerings such as bioactive dressings, negative pressure wound therapy, and other high-performance solutions. Despite strong global demand, especially in aging populations and among those with chronic conditions, high product costs continue to hinder broader adoption in price-sensitive regions.

Key Market Drivers

Increasing Incidence of Biliary Diseases

The growing incidence of chronic and acute wounds is a central factor accelerating the global advanced wound care market. Globally, chronic wounds affect approximately 1.51 to 2.21 individuals per 1,000 people, representing a substantial segment of patients requiring long-term care. Chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are often linked to underlying conditions such as diabetes, cardiovascular disease, and obesity. These wounds typically do not respond to standard dressings and demand advanced treatment solutions like antimicrobial dressings, hydrogels, and negative pressure wound therapy to prevent severe complications. The increasing burden of noncommunicable diseases-accounting for over 43 million deaths in 2021-further elevates the demand for effective and technologically advanced wound care products across both developed and emerging markets.

Key Market Challenges

High Cost of Advanced Wound Care Products

A significant challenge to the expansion of the advanced wound care market is the high cost of products like negative pressure wound therapy systems and collagen-based dressings. These premium solutions often exceed the budget constraints of healthcare providers in low- and middle-income countries. The elevated price points not only restrict access for individual patients but also strain public health budgets and insurance systems, limiting adoption even in moderately developed regions. As affordability remains a barrier, companies must focus on creating cost-effective alternatives without compromising on efficacy to enhance market penetration.

Key Market Trends

Increasing Focus on Regenerative Medicine and Biologics

A notable trend shaping the advanced wound care market is the increasing integration of regenerative medicine and biologics into wound treatment. Solutions such as growth factors, stem cell therapies, and bioengineered dressings are gaining traction for their ability to promote faster healing, particularly in chronic wound cases. These biologic therapies address underlying healing deficiencies, offering improved outcomes and reducing complications. Healthcare providers are showing a growing preference for such high-efficacy treatments, and companies investing in these biologic-based innovations are poised to benefit from expanding market opportunities as demand for sophisticated, targeted therapies increases.

Key Market Players

• Convatec Group PLC
• Smith+Nephew
• Molnlycke AB
• B. Braun SE
• 3M Company
• Urgo Group
• Coloplast Corp
• Integra LifeSciences Corporation
• Medline Industries, LP.
• Boston Scientific Corporation

Report Scope:

In this report, the Global Advanced Wound Care Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Advanced Wound Care Market, By Product:

• Moist
• Antimicrobial
• Active

Advanced Wound Care Market, By Application:

• Chronic Wounds
• Acute Wounds

Advanced Wound Care Market, By End User:

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Advanced Wound Care Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Advanced Wound Care Market.

Available Customizations:

Global Advanced Wound Care market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Advanced Wound Care Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Moist, Antimicrobial, Active)
  • 5.2.2. By Application (Chronic Wounds, Acute Wounds)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Home Healthcare, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Advanced Wound Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Advanced Wound Care Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Advanced Wound Care Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Advanced Wound Care Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Advanced Wound Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Advanced Wound Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Advanced Wound Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Advanced Wound Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Advanced Wound Care Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Advanced Wound Care Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Advanced Wound Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Advanced Wound Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Advanced Wound Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Advanced Wound Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Advanced Wound Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Advanced Wound Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Advanced Wound Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Advanced Wound Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Advanced Wound Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Advanced Wound Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Advanced Wound Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Advanced Wound Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Advanced Wound Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Advanced Wound Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Advanced Wound Care Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Convatec Group PLC
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Smith+Nephew
• 14.3. Molnlycke AB
• 14.4. B. Braun SE
• 14.5. 3M Company
• 14.6. Urgo Group
• 14.7. Coloplast Corp
• 14.8. Integra LifeSciences Corporation
• 14.9. Medline Industries, LP.
• 14.10.Boston Scientific Corporation.

15. Strategic Recommendations

16. About Us & Disclaimer